Cantor starts Portage Biotech at OW; PT $35 - BioTuesdays
Aug 19, 2021 · Cantor Fitzgerald launched coverage of Portage Biotech (NASDAQ:PRTG) with an “overweight” rating and $35 price target. The stock closed at $18.95 on Aug. 18. Portage …
OFF
Cantor Starts Portage Biotech At OW; PT $35 - BioTuesdays
1 week from now
Aug 19, 2021 · Cantor Fitzgerald launched coverage of Portage Biotech (NASDAQ:PRTG) with an “overweight” rating and $35 price target. The stock closed at $18.95 on Aug. 18. Portage …
biotuesdays.com
OFF
--Cantor Fitzgerald Starts Portage Biotech At Overweight With $35 …
1 week from now
--Cantor Fitzgerald Starts Portage Biotech at Overweight With $35 Price Target. MT Newswires · 08/19/2021 03:45. FAQ. Fee Schedule Account Margin Trading How to File an Inquiry …
webull.com
OFF
Cantor Starts PAVmed At OW; PT $8 | BioTuesdays : R/PAVM - Reddit
1 week from now
Posted by u/IvyMalise - 5 votes and no comments
reddit.com
OFF
Cantor Starts DarioHealth At OW; PT $35 - BioTuesdays
1 week from now
Feb 25, 2021 · Cantor Fitzgerald launched coverage of DarioHealth (NASDAQ:DRIO) with an “overweight” rating and price target of $35. The stock closed at $29.16 on Feb. 24. The stock …
biotuesdays.com
OFF
Cantor Starts Arcturus Therapeutics At OW; PT $71 - BioTuesdays
1 week from now
Jul 2, 2021 · Cantor starts Arcturus Therapeutics at OW; PT $71. ... The stock closed at $35.94 on July 1. Arcturus is leveraging its proprietary lipid-based delivery platform to develop the …
biotuesdays.com
OFF
Cantor Starts EFFECTOR Therapeutics At OW; PT $50 - BioTuesdays
1 week from now
Sep 13, 2021 · Cantor Fitzgerald launched coverage of eFFECTOR Therapeutics (NASDAQ:EFTR) with an “overweight” rating and price target of $50. The stock closed at …
biotuesdays.com
OFF
Cantor Starts Ocugen At OW; PT $4.50 - BioTuesdays
1 week from now
Jun 2, 2022 · Cantor Fitzgerald launched coverage of Ocugen (NASDAQ:OCGN) with an “overweight” rating and price target of $4.50. The stock closed at $2.17 on June 1. The stock …
biotuesdays.com
OFF
Cantor Starts Aytu BioPharma At OW; PT $11 - BioTuesdays
1 week from now
Cantor Fitzgerald launched coverage of Aytu BioPharma (NASDAQ:AYTU) with an “overweight” rating and $11 price target. The stock closed at $7.49 on March 29. “Through a strategy of in …
biotuesdays.com
OFF
Cantor Starts Lineage Cell Therapeutics At OW; PT $6
1 week from now
Mar 31, 2021 · Cantor Fitzgerald launched coverage of Lineage Cell Therapeutics (NYSE American: LCTX) with an “overweight” rating and 12-month price target of $6. The stock …
biotuesdays.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension